Clinical Trial Update: A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan [Phase 2]

View source ↗

Summary

Phase 2 trial in Japan evaluating aflibercept with FOLFIRI in second-line metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Aflibercept (Aflibercept)
• Folinic acid (folinic acid)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2017-03-14